Avricore Health (AVCRF) Liabilities and Shareholders Equity (2009 - 2025)

Avricore Health has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $403809.2 for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 75.46% year-over-year to $403809.2; the TTM figure through Dec 2025 stood at $4.1 million (down 48.25% YoY), while the FY2025 annual figure was $403040.6, down 75.99% from the prior year.
• Liabilities and Shareholders Equity retreated to $403809.2 in Q4 2025, from $965908.6 in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for AVCRF reached as high as $2.2 million in Q3 2024 and fell as low as $403809.2 in Q4 2025.
• The 5-year median for Liabilities and Shareholders Equity is $1.8 million (2021), against an average of $1.7 million.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity surged 649.04% — and 2025, when it plunged 75.46%.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.8 million in 2021, then advanced by 4.57% to $1.9 million in 2022, then fell by 1.49% to $1.9 million in 2023, then declined by 11.75% to $1.6 million in 2024, then sank by 75.46% to $403809.2 in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $403809.2, $965908.6, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.